Abstract: Crystal proteins of Bacillus thuringiensis are known for their insecticidal specificity. This specificity is, to a large extent, determined by the interaction of the proteins with high-affinity binding sites on the epithelial membrane of the midgut of sensitive insects. In particular, domain II of the three domains of the toxic moiety has been implicated in specificity. To determine which sequences of the protein are involved in binding, loops of domain II which terminate in the molecular apex of CrylA(b) were replaced by the corresponding regions of CrylE, a protein with different binding characteristics and insect specificity. In contrast to expression of the wild-type genes, expression of the mutant alleles in Escherichia coil resulted in the formation of biologically inactive, insoluble aggregates. Although these aggregates could be solubilized in vitro using urea, in contrast to the wild-type CrylA(b), the mutant proteins did not correctly refold as is shown by their increased protease sensitivity and lack of biological activity. The results indicate that engineering CryI proteins, based on the CrylIIA structure, is likely to prove difficult, particularly since the conformation of CrylIIA and CryI proteins might differ in domain II.
Introduction
Bacillus thuringiensis is capable of producing proteins that accumulate as crystals and are toxic to a number of insect larvae. Of these, the best studied are the CryI class of proteins which are synthesized as 140 kD protoxins and are active against lepidopterans [1] .
To some extent, different steps in the mode of action of crystal proteins have been elucidated and simulated in vitro. After oral uptake, the crystals dissolve in the alkaline environment of the larval midgut and are subsequently processed by midgut proteases to 65 kDa protease-resistant toxic fragments [2] . The toxic fragment binds to receptors on epithelial cells of the insect midgut [3, 4] and penetrates the cell membrane eventually leading to death of the larvae [5] . The activity spectrum of a particular crystal protein is, to a large extent, determined by the binding charac-130 teristics of the protein to receptors on the midgut epithelial cells of insects [3, 4, 6] .
As can be deduced from the 3-dimensional (3-D) structure of the beetle-specific CrylIIA protein [7] , toxic fragments of crystal proteins are composed of three distinct structural domains of which domain II is comprised of three anti-parallel /3-sheets which are oriented in a triangular conformation. The ribbons from these sheets terminate in loops in a small region on the molecular apex. The 3-D structure of domain II, combined with data from receptor-binding experiments with hybrid crystal proteins [8, 9] , suggest that these loops might be involved in receptor binding [7] . To test this hypothesis, loops of CrylA(b) were substituted by the corresponding regions of CrylE, a crystal protein with different receptor-binding characteristics [6] and insecticidal specificity. 
Materials and Methods

DNA manipulations and plasmids
All recombinant DNA manipulations were performed as described [10] . Plasmids pBD1400 and pBD1600 carry the crylA(b) and crylE genes respectively and are derivatives of pKK233-2 (Pharmacia). Expression of these genes is under control of the lac promoter and introduction of these plasmids into E. coli results in high level expression of CrylA(b) and CrylE respectively. Site-directed mutagenesis was performed according to the method described by Kunkel [11] Fig. 1 ). Plasmid pBD43ABCD, encoding a CrylA(b) derivative in which all four loops were exchanged, was constructed by introducing the 817 bp SpeI-EcoR/restriction fragment carrying the loop mutations of pBD43AB, into the proper position of pBD43CD after deletion of the corresponding wild-type sequences. Subsequently, the SpeI-AflH fragments of pBD43 ABCD, pBD43AB and pBD43CD were ligated into CrylA(b) expression vector pBD1400, resulting in mutant expression plasmids pBD1401, pBD1402 and pBD1403 respectively. DNA sequencing was performed by the dideoxytriphosphate method [12] with fluorescent dyes attached to the dideoxynucleotides. Analysis was automated by using an Applied Biosystems 370A nucleotide sequence analyzer.
Protein man~ulation and analysis
Isolation and solubilization of inclusions at high pH has been described previously [13] . Inclusions were incubated with 50 mM NaHCO3, 200 mM NaC1, 10 mM dithiothreitol, pH 10 for 8 h at 37°C. Alternatively, inclusions were incubated with 8 M urea, 200 mM NaCI, 10 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 50 mM NaHCO 3 pH 10 for 8 h. The samples were centrifuged for 15 min at 14 000 × g to remove undissolved material and the supernatants were dialysed against the same buffer without urea. Subsequently, all samples were dialysed against 20 mM Tris. HCI, 200 mM NaCI, pH 8. Trypsin incubations were performed in 20 mM Tris. HC1, 200 mM NaCI, pH 8 for 1 h at 4°C at the appropriate enzyme concentrations. Proteins were analysed by electrophoresis in 7.5% sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE).
Toxicity assays were performed on first-instar larvae. Diluted samples of E. coli cells expressing CryI derivatives or diluted samples of crystal protein inclusions were fed to Manduca sexta and the growth reduction was scored as described previously [8] .
Results and Discussion
Domain II of CrylIIA is composed of three antiparallel/3-sheets, from which four loops protrude towards the apex of the molecule [7] (Fig.  1) . Sheets 1 and 2 each terminate in loops defined as loop-I and loop-II, and run from amino acid residues 350-360 and residues 407-420 respectively. From sheet 3, two loops protrude which are well separated in the primary amino acid sequence. The loop running from amino acid residues 305-337 is designated loop-Ilia, whereas the loop running from residues 481-486 is termed loop-IIIfl. Based on the alignment of CrylIIA, CrylA(b) and CrylE, the corresponding loops in CrylA(b) and CrylE can be determined (Fig. 1) . To test the hypothesis that these loops are involved in receptor binding and insect specificity, the DNA encoding loops IIIfl, I, II and IIIa of CrylA(b) was substituted by the corresponding regions of CrylE by site-directed mutagenesis (see Materials and Methods). To minimize mistakes in assigning cross-over points, the cross-overs between CrylA(b) and CrylE were chosen in relatively conserved regions flanking the hypervariable loops as indicated in Fig. 1 . Four plasmids were constructed carrying the wild-type and three mutant crylA(b) alleles. Plasmid pBD1400 encodes wild-type CrylA(b), and pBD1401 encodes a derivative of CrylA(b) in which all four loops have been substituted. In pBD1402, the regions encoding loop-IIIa and loop-I were substituted, whereas in pBD1403 the regions of CrylA(b) encoding loop-II and loop-IIIfl were substituted. The mutations were verified by DNA sequence analysis.
The crylA(b) alleles on pBD1400, pBD1401, pBD1402, pBD1403 and the crylE gene on pBD1600, were expressed in E. coli and analysis of these cells by SDS-PAGE indicated, in all cases, high level expression of proteins of the expected molecular mass of 140 kDa (data not shown). Subsequently, these cells were used in toxicity studies against larvae of M. sexta. As expected, cells expressing the wild-type CrylA(b) or CrylE proteins were toxic against M. sexta. However, although expressed at equal levels, none of the cells expressing mutant proteins showed any activity towards M. sexta (data not shown).
In E. coli, wild-type CrylA(b) is produced as crystals which can be isolated after disruption of the cells and subsequent pelleting of the crystals (Fig. 2, lane A) . These crystals can then be solubilized at high pH in the presence of dithiothreitol (lane E). Although the mutant proteins could be isolated as inclusions by centrifugation (lanes B-D), these inclusions could not be solubilized at high pH (lanes F-H). Apparently the mutant proteins precipitate in E. coli as insoluble aggregates which would not be expected to be toxic to insects, since proper proteolytic activation, receptor binding, and subsequent membrane penetration cannot occur. High level expression of proteins in E. coli often results in the formation of insoluble aggregates. To obtain soluble, active proteins, the inclusions have to be denatured and the released denatured proteins are subsequently allowed to refold. Similarly, the aggregates isolated from E. coli cells expressing pBDI400, pBDI401, pBD 1402 and pBD1403 were solubilized in a buffer containing 8 M urea. CryIA(b) and all derivatives remained in solution after dialysis against Tris. HCI, 200 mM NaCI pH 8 (Fig. 3, lanes A-D) . Subsequent incubation of wild-type CryIA(b) with trypsin resulted in the characteristic conversion of protoxin to 65 kDa fragment (Fig. 3, lane I) , providing evidence that denatured CryIA(b) protoxin rcfolds correctly during dialysis. This was confirmed by the observation that this dialysed sample was toxic to M. sexta larvae (data not shown). In contrast, even under limiting trypsin concentrations (lane E), the solubilized mutant proteins were completely degraded 0anes F-H). This suggested that these proteins do not refold correctly, and that trypsin-sensitive sites normally buried in the protein, become exposed. This explains the observation that these solubilized proteins were not toxic to M. sexta larvae (data not shown). Most likely, when fed to larvae, the in vitro-solubilized mutant proteins are also proteolytically degraded in the insect midgut. Since no 65 kDa fragments of the mutant proteins could be isolated, no receptor binding experiments could be performed.
The data show that limited modifications, even in putative exposed regions of crystal proteins, prevent the mutant proteins from normal folding resulting in proteins with altered solubilization characteristics and increased sensitivity to proteases. Although the reason for this misfolding is not clear, intramolecular interactions are probably disturbed due to the mutations. The toxins must fold into compact structures with few exposed loops, so as to avoid digestion in the insect gut. Possibly, the mutations at the apex of domain II alter the positioning of/3-strands in the entire domain, and change it into a more loosely folded structure which is more sensitive to protease digestion. The results might also indicate that, as far as domain II is concerned, the conformation of CryI and CryIIIA proteins differ, and that (some of) the amino acid residues of CrylA(b) modified in this study are not surface exposed, but buried in the protein and involved in packing of the molecule. Substituting surface exposed residues for packing residues or vice versa could cause the observed misfolding. It should be noted that the loop between /32 and /33, designated here as loop-I (Fig. 1) , is much more extended in CrylIIA than the corresponding loop in the CryI proteins. In fact, the /3-sheet designated /33r in CrylIIA [7] does not seem to be present in CryI proteins ( Fig. 1) and it is unlikely that the remaining amino_acid residues in this region of CryI proteins allow the formation of an exposed loop. Although less pronounced, the reverse situations seems to hold for loop-II. The length of the sequence between /36 and /37r of CrylIIA is markedly shorter than the corresponding regions of CryI proteins.
If, indeed, the structures of CryIIIA and CryI proteins differ in domain II, protein engineering on CryI proteins which is based on the CrylIIA structure, is likely to prove difficult. Reliable conclusions based on such experiments may then only be drawn when at least some of the characteristics of the crystal protein are not affected by the mutations. Preferably, biological activity against at least one insect should be retained or, alternatively, biochemical characteristics such as solubility of the crystalline inclusions and conversion of protoxin to toxin could be used as criteria that folding into a conformation similar to the wild-type protein had occurred.
